Back to Search
Start Over
Long-Term Benefit of Empagliflozin on Life Expectancy in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease.
- Source :
- Circulation; 10/9/2018, Vol. 138 Issue 15, p1599-1601, 3p
- Publication Year :
- 2018
Details
- Language :
- English
- ISSN :
- 00097322
- Volume :
- 138
- Issue :
- 15
- Database :
- Complementary Index
- Journal :
- Circulation
- Publication Type :
- Academic Journal
- Accession number :
- 132198893
- Full Text :
- https://doi.org/10.1161/CIRCULATIONAHA.118.033810